Loading…
Caribou Biosciences, Inc. is projected to rise to $1.84 by 2027, a +26% move from its current price of $1.46. CRBU is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $1.42 | $1.46 | $1.50 | +0.03% |
| Aug 5 | $1.40 | $1.46 | $1.52 | +0.06% |
| Aug 6 | $1.39 | $1.46 | $1.54 | +0.09% |
| Aug 7 | $1.38 | $1.46 | $1.55 | +0.13% |
| Aug 8 | $1.37 | $1.46 | $1.56 | +0.16% |
| Aug 9 | $1.36 | $1.46 | $1.57 | +0.19% |
| Aug 10 | $1.36 | $1.46 | $1.58 | +0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.36 | $1.46 | $1.58 | +0.22% |
| Week 2 | $1.32 | $1.47 | $1.63 | +0.44% |
| Week 3 | $1.29 | $1.47 | $1.67 | +0.66% |
| Week 4 | $1.27 | $1.47 | $1.71 | +0.88% |
| Week 5 | $1.25 | $1.48 | $1.75 | +1.11% |
| Week 6 | $1.23 | $1.48 | $1.78 | +1.33% |
| Week 7 | $1.21 | $1.48 | $1.81 | +1.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Caribou Biosciences, Inc. operates as a clinical-stage CRISPR genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies.
The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Caribou Biosciences, Inc. trades as CRBU and currently sits with a price of $1.49 per share. It has a market capitalization of $147.78M and a market rank of 3832. The stock’s near-term price action and longer-term outlook are reflected in the latest technicals and the year-by-year forecasts.
A major floor 21.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 32.9% above — a clean break opens room to run.
A major ceiling 66.4% above — clearing it would confirm fresh momentum.
Key CRBU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRBU market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.50 | Sell | $1.51 | Sell |
| MA 10 | $1.57 | Sell | $1.56 | Sell |
| MA 20 | $1.69 | Sell | $1.63 | Sell |
| MA 50 | $1.81 | Sell | $1.75 | Sell |
| MA 100 | $1.90 | Sell | $1.82 | Sell |
| MA 200 | $1.89 | Sell | $1.84 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.67 | Neutral |
| Stoch RSI (14) | 12.86 | Buy |
| CCI (20) | -116.30 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -15.61 | Sell |
| Bollinger %B (20,2) | 0.13 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.54 | Sell |
| Awesome (5,34) | -0.18 | Sell |
| Ultimate (7,14,28) | 22.06 | Buy |
| Momentum (10) | -0.19 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 1.45 | Buy |
| ADX (14) | 24.28 | Sell |
| ATR (14) | 0.04 | Info |
The near-term picture shows Bearish sentiment with an RSI of 40. The stock’s 50-day simple moving average sits at $1.87 and the 200-day simple moving average at $1.91. Immediate support is at $1.57 and resistance at $1.94. Over the last 30 days, the price range has been between $1.24 and $1.79.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.39 | $1.46 | $2.05 | 0% | Neutral | |
| $1.46 | $1.84 | $2.45 | +26% | Bullish | |
| $1.57 | $2.04 | $2.83 | +40% | Bullish | |
| $1.56 | $2.07 | $2.96 | +42% | Bullish | |
| $1.43 | $1.94 | $2.84 | +33% | Bullish | |
| $1.60 | $2.22 | $3.32 | +52% | Bullish | |
| $1.82 | $2.56 | $3.91 | +75% | Bullish | |
| $1.96 | $2.81 | $4.37 | +93% | Bullish | |
| $2.12 | $3.09 | $4.89 | +112% | Bullish | |
| $2.09 | $3.09 | $4.96 | +112% | Bullish | |
| $2.84 | $4.52 | $7.74 | +210% | Bullish | |
| $4.63 | $8.32 | $15.61 | +470% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.39 | $1.46 | $1.82 | +0.00% |
| September 2026 | $1.28 | $1.51 | $1.84 | +3.66% |
| October 2026 | $1.26 | $1.50 | $1.85 | -0.73% |
| November 2026 | $1.31 | $1.57 | $1.95 | +4.54% |
| December 2026 | $1.35 | $1.63 | $2.05 | +3.94% |
Click any year to see its month-by-month CRBU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CRBU price prediction for 2026 points to an average of $1.46 (low $1.39, high $2.05) — a potential gain of 0% on today's $1.46. A consolidation phase looks the most probable path here.
In 2027, CRBU is projected to trade between $1.46 and $2.45, averaging $1.84 — a potential gain of +26% from today's $1.46. That is up +26% on the projected 2026 average. Momentum favours further upside here.
Caribou Biosciences, Inc.'s 2028 outlook centres on $2.04, within a $1.57 to $2.83 range. That is up +11% on the projected 2027 average. That marks a +40% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, CRBU could reach as high as $2.96, with a base case around $2.07 and support toward $1.56 — roughly +42% from $1.46. Momentum favours further upside here.
Expect CRBU to range from $1.43 to $2.84 through 2030. The $1.94 average target implies a +33% move from current prices. That is -7% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The CRBU price prediction for 2031 points to an average of $2.22 (low $1.60, high $3.32) — a potential gain of +52% on today's $1.46. Momentum favours further upside here.
In 2032, CRBU is projected to trade between $1.82 and $3.91, averaging $2.56 — a potential gain of +75% from today's $1.46. That is up +15% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Caribou Biosciences, Inc.'s 2033 outlook centres on $2.81, within a $1.96 to $4.37 range. That is up +10% on the projected 2032 average. That marks a +93% change versus current levels. Momentum favours further upside here.
By 2034, CRBU could reach as high as $4.89, with a base case around $3.09 and support toward $2.12 — roughly +112% from $1.46. Buyers look set to stay in control over this stretch.
Expect CRBU to range from $2.09 to $4.96 through 2035. The $3.09 average target implies a +112% move from current prices. That is 0% versus the projected 2034 average. Momentum favours further upside here.
The CRBU price prediction for 2040 points to an average of $4.52 (low $2.84, high $7.74) — a potential gain of +210% on today's $1.46. Buyers look set to stay in control over this stretch.
In 2050, CRBU is projected to trade between $4.63 and $15.61, averaging $8.32 — a potential gain of +470% from today's $1.46. That is up +84% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CRBU today (≈ 684.931507 CRBU) could be worth
$5,696.23
+$4,696.23 (+470%) by 2050 · US Dollar
Based on the average projected CRBU price of $8.32 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRBUwould be worth at today's price.
$1,000 invested in CRBU on Jul 31, 2025 (≈ 492.610844 CRBU) would be worth
$719.21
-$280.79 (-28.1%) today · 0.72× · US Dollar
Based on a CRBU entry price of $2.03 vs. today's $1.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.57 | $929.94 | -7.0% |
| 1 month ago | $1.76 | $829.55 | -17.0% |
| 3 months ago | $1.87 | $780.75 | -21.9% |
| 6 months ago | $1.46 | $1,000 | -0.0% |
| 1 year ago | $2.03 | $719.21 | -28.1% |
| All time (5.0y) ago | $18.05 | $80.89 | -91.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRBU forecast.
Our base-case forecast reaches $2.90 around 2034.
Implied market cap at $2.90: $287.62M
The multi-year forecast indicates a bullish trend continuing into the 2030s and beyond. For 2026 the average price is $1.49 with a min of $1.39 and a max of $2.10, and an ROI of 0% (neutral sentiment). From 2027 onward, the model projects rising averages and positive momentum, with 2027 averaging $1.90 (ROI 27.3%), 2028 averaging $2.12 (ROI 42.2%), and 2029 averaging $2.16 (ROI 45%).
The 2030 forecast shows an average price of $2.05 with a max of $2.98 and an ROI of 37.5% (bullish). The trajectory continues through 2031–2035 with higher averages and continued bullish sentiment, reaching 2035’s average of $3.36 and max of $5.35 (ROI 125.5%). In 2040 the average is projected at $5.03 with a max of $8.53 and an ROI of 237.8%.
By 2050 the average is $9.47, with a max of $17.58 and an ROI of 535.3% (bullish). These figures illustrate substantial upside potential over the longer term, though they are estimates, not guarantees.
Tap a question to reveal the answer.
The forecast shows a 2030 average price of $2.05, with a min of $1.52, a max of $2.98, and an ROI of 37.5%. The sentiment is bullish.
The long-term outlook is bullish, with rising averages and strong upside in later years (e.g., 2040 ROI 237.8%, 2050 ROI 535.3%). The 2026 projection is neutral with an average of $1.49 and ROI of 0%, so outcomes vary across the forecast horizon.
Yes. The forecast shows max prices above $5 in several years: 2034 max $5.28, 2035 max $5.35, 2040 max $8.53, and 2050 max $17.58.
Current price is $1.49 and the market capitalization is $147.78M. The asset ranks 3832.
The near-term view is bearishly inclined with RSI 14 at 40. The 50-day SMA is $1.87, the 200-day SMA is $1.91, with support at $1.57 and resistance at $1.94. The 30-day price range is $1.24 to $1.79.
Caribou Biosciences, Inc. Community Discussion
0Share your Caribou Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.